ampicillin has been researched along with dactinomycin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Martins, T; Melo, IS; Queiroz, SCN; Reyes, FGR; Schinke, C | 1 |
| Copley, GC; Elshahawi, SI; Hatcher, BE; Hower, JC; Kharel, MK; Liu, Y; Ponomareva, LV; Shaaban, KA; She, QB; Thorson, JS; Van Lanen, SG; Voss, SR; Wang, X; Ye, Q | 1 |
| Boutibonnes, P | 1 |
| Normark, S | 1 |
| Hanka, LJ | 1 |
| Gray, J; Warren, GH | 1 |
| Beaty, HN; Petersdorf, RG | 1 |
| Byeon, WH; Choi, EY; Chung, JK; Shin, HC; Yoon, HE | 1 |
| Okonogi, K; Tsuchimori, N; Yamazaki, T | 1 |
| Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
| Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
| Fujii, K; Hishiki, H; Hotta, M; Ishiwada, N; Murata, S; Ohkusu, M; Takeuchi, N | 1 |
2 review(s) available for ampicillin and dactinomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antibacterial Compounds from Marine Bacteria, 2010-2015.
Topics: Actinobacteria; Anti-Bacterial Agents; Bacteria; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
13 other study(ies) available for ampicillin and dactinomycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated
Topics: Anti-Bacterial Agents; Antifungal Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Gram-Positive Bacteria; Humans; Molecular Structure; Quinolones; Spectrum Analysis; Streptomyces | 2019 |
[Various properties of a stable variant of Bacillus thuringiensis (Berliner) resistant to aflatoxin B1].
Topics: Aflatoxins; Ampicillin; Bacillus; Benzopyrenes; Cell Membrane Permeability; Dactinomycin; Genetic Variation; Nalidixic Acid; Penicillin Resistance; Sodium Chloride; Surface-Active Agents; Temperature | 1974 |
Genetics of a chain-forming mutant of Escherichia coli. Transduction and dominance of the envA gene mediating increased penetration to some antibacterial agents.
Topics: Ampicillin; Cell Membrane Permeability; Dactinomycin; Escherichia coli; Genetics, Microbial; Penicillin Resistance; Rifampin; Suppression, Genetic | 1970 |
Microbiological assay for cytosine arabinoside (NSC-63878) in biologic materials containing other antitumor or antibacterial drugs.
Topics: Ampicillin; Biological Assay; Cephalothin; Chloramphenicol; Cytarabine; Dactinomycin; Depression, Chemical; Drug Antagonism; Enterococcus faecalis; Erythromycin; Leucovorin; Lincomycin; Methods; Methotrexate; Nucleosides; Penicillins; Tetracycline | 1971 |
Effect of antimicrobial drug combinations on enzymic lysis of Staphylococcus aureus.
Topics: Ampicillin; Bacteriolysis; Cephalothin; Chloramphenicol; Cloxacillin; Dactinomycin; Erythromycin; Muramidase; Nafcillin; Staphylococcus; Tetracycline; Trypsin | 1967 |
Effect of inhibitors of protein synthesis on pyrogen production by granulocytes.
Topics: Ampicillin; Animals; Chloramphenicol; Dactinomycin; In Vitro Techniques; Leukocytes; Protein Biosynthesis; Puromycin; Pyrogens; Rabbits; RNA | 1967 |
Induction of growth phase-specific autolysis in Bacillus subtilis 168 by growth inhibitors.
Topics: Ampicillin; Anti-Bacterial Agents; Bacillus subtilis; Bacteriolysis; Cell Wall; Chloramphenicol; Dactinomycin; Enzyme Induction; Enzyme Inhibitors; Glucose; Growth Inhibitors; Ionophores; N-Acetylmuramoyl-L-alanine Amidase; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Rifampin; Sodium Azide; Sodium Dodecyl Sulfate; Surface-Active Agents | 2009 |
Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice.
Topics: Ampicillin; Animals; Cefozopran; Ceftazidime; Cephalosporins; Cilastatin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Imipenem; Mice; Mice, Inbred CBA; Ofloxacin; Pseudomonas Infections; Urinary Tract Infections | 1997 |
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Microbial Sensitivity Tests; Myopathies, Structural, Congenital; Ophthalmoplegia; Pneumonia, Pneumococcal; Ryanodine Receptor Calcium Release Channel; Sputum; Streptococcus pneumoniae; Sulbactam | 2020 |